HuBMAP Funded Research

There are currently 29 funded components that make up the HuBMAP Consortium. These research groups come from universities and institutions across the United States and the globe, and have formed meaningful partnerships with one another to begin building the human body atlas. HuBMAP is divided into four categories based on the type of work being undertaken by each group. Read more about the categories below, and click through to learn about the fascinating work of our funded research components.

HuBMAP Infrastructure, Visualization & Engagement

The HIVE contains several teams: two Mapping Components which are responsible for building an atlas of tissue maps; two Tools Components, which are developing novel tools for visualizing, searching and modelling data; and the IEC (Infrastructure, Engagement and Communications) which manages and maintains the HuBMAP infrastructure and the data generated by the Consortium and coordinates internal and external Consortium activities.

Rapid Technology Implementation

The RTIs focus on enhancing, large-scale validation, and integration of emerging new technologies into the HuBMAP Consortium. Their goal is to improve the quality and throughput of atlas generation at key steps of the production pipeline including sample collection, tissue mapping, and data integration and analysis.

Tissue Mapping Centers

TMCs collect and analyze a range of normal tissues from both male and female donors with a variety of ages and ethnicities. The samples collected range from discrete, complex organs through distributed organ systems and systems comprising dynamic or motile cell types with distinct microenvironments. The organs being studied include the bladder, kidney/ureter, colon, lung, lymph nodes, spleen, thymus, pancreas, eye, uterus, fallopian tubes, ovaries, tooth, cartilage, heart, bone and vasculature.

Transformative Technology Development

TTDs collect and analyze tissue along with the TMCs, including tissue from the heart, aorta, skin, kidney, endothelial cells, liver, pancreas, uterus, and breast. TTDs also provide proof-of-principle with initial validation of transformative new tools, techniques and methods for mapping the human body at high resolution.